Gene · 466
Papers2,331
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,331
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Rare Case of Clear Cell Sarcoma of the Tongue: A Case Report. | Cureus | 2023 | 38234940 | PubTator, text mining | PubMed |
| The Role of microRNA in Spermatogenesis: Is There a Place for Fertility Preservation Innovation? | Int J Mol Sci | 2023 | 38203631 | PubTator, text mining | PubMed |
| Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas. | Cancers (Basel) | 2023 | 38201593 | PubTator, text mining | PubMed |
| Case Report: Angiomatoid fibrous histiocytoma in the hand: a rare clinical presentation and diagnostic challenge. | Front Oncol | 2023 | 38148839 | PubTator, text mining | PubMed |
| EWSR1::ATF1 Orchestrates the Clear Cell Sarcoma Transcriptome in Human Tumors and a Mouse Genetic Model. | Cancers (Basel) | 2023 | 38136296 | PubTator, text mining | PubMed |
| Malignant gastrointestinal neuroectodermal tumor: a case report and literature review. | Ann Med Surg (Lond) | 2023 | 38098564 | PubTator, text mining | PubMed |
| Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development. | Front Genet | 2023 | 38094755 | PubTator, text mining | PubMed |
| Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapy. | Front Oncol | 2023 | 38094610 | PubTator, text mining | PubMed |
| Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma. | Cell Div | 2023 | 38082448 | PubTator, text mining | PubMed |
| A Clear Cell Sarcoma Case: A Diagnostic and Treatment Challenge, with a Promising Response to Trabectedin. | Case Rep Oncol | 2023 | 38074516 | PubTator, text mining | PubMed |
| Hotspots of Somatic Genetic Variation in Pituitary Neuroendocrine Tumors. | Cancers (Basel) | 2023 | 38067388 | PubTator, text mining | PubMed |
| The Role of Gene Fusions in Thymic Epithelial Tumors. | Cancers (Basel) | 2023 | 38067300 | PubTator, text mining | PubMed |
| The role of AMPK in macrophage metabolism, function and polarisation. | J Transl Med | 2023 | 38066566 | PubTator, text mining | PubMed |
| Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types. | F1000Res | 2023 | 38046195 | PubTator, text mining | PubMed |
| Circular RNA in Multiple Sclerosis: Pathogenicity and Potential Biomarker Development: A Systematic Review. | Epigenet Insights | 2023 | 38033465 | PubTator, text mining | PubMed |
| Identification of genetic associations and functional SNPs of bovine KLF6 gene on milk production traits in Chinese holstein. | BMC Genom Data | 2023 | 38017423 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway. | Mol Cell Biol | 2023 | 38014992 | PubTator, text mining | PubMed |
| Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer. | Nat Commun | 2023 | 37990009 | PubTator, text mining | PubMed |
| Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer. | Explor Target Antitumor Ther | 2023 | 37970212 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/466/papers?page=7